Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study

Metastasis-directed therapy guided by gallium 68 ( 68 Ga) prostate-specific membrane antigen (PSMA)-11 PET/CT improved metastasis-free survival but not local recurrence-free survival compared with fluorine 18 ( 18 F)-PSMA-1007 and 18 F-fluorocholine PET/CT in patients with nodal or bone oligorecurrent prostate cancer.